In the same way, celastrol administration has been found to relieve the severity of colitis by decreasing IL-1β, IL-6, myeloperoxidase (MPO), RIPK3, and MLKL levels while increasing active caspase-8 levels and E-cadherin [128]. This evidence concerns the gene RIPK3 and colitis.